Women with uterine fibroids (UF) experience higher rates of depression, anxiety, and self-directed violence, especially those with pain or who have had a hysterectomy, according to a study published in the Journal of Epidemiology and Community Health.
Cohort study participants were selected from the Optum Clinformatics commercial insurance claims database in Eden Prairie, Minnesota between May 1, 2000 and March 1, 2020 in order to evaluate the mental health risks of UF.
Stephanie E Chiuve, ScD, general medicine and neuroscience therapy area head, global epidemiology, at AbbVie Pharmaceutical Research and Development in North Chicago, Illinois and colleagues compared 313,754 women aged 18-50 that had been diagnosed with UF with 627,539 who did not have fibroids.
Women with UF were matched 1:2 with women who were not diagnosed with UF based on age and calendar time. Women with a prior diagnosis of depression, anxiety, self-violence, or who had been prescribed anti-anxiety or anti-depressant medication were excluded from the study.
Other exclusionary categories included cancer diagnosis, prior hysterectomy, and women who did not have UF who did not start follow up or had incomplete cases. Researchers also conducted a secondary analysis in 50,525 women who had a hysterectomy to see if these women were also at higher risk.
Researchers reported a median follow up time of 596 days for anxiety, 608 days for depression, and 665 days for self-directed violence. After confounder adjustment, researchers reported that women who had been diagnosed with UF had higher rates of anxiety (HR: 1.12; 95% CI 1.10 to 1.13), depression n (HR:1.12; 95% CI 1.10 to 1.13), and self-directed violence (HR: 1.46; 95% CI 1.29 to 1.64).1
For women with heavy menstrual bleeding and pain, the HR for depression that compared women with diagnosed UF to women without was 1.21 (95% CI 1.18 to 1.25), 1.68 (95% CI 1.35 to 2.09) for self- directed violence, and 1.18 (95% CI 1.15 to 1.21) for anxiety, according to researchers.
In addition, Chiuve and colleagues wrote, “Among women with diagnosed UF, the HR comparing women who underwent a hysterectomy to women who did not was 1.22 (95% CI 1.17 to 1.27) for depression, 1.13 (95% CI 1.09 to 1.17) for anxiety and 1.86 (95% CI 1.39 to 2.49) for self- directed violence.”1
Researchers said there may be a link between chronic pain and depression due to similar biological mechanisms, and noted the higher rates of both anxiety and depression in patients with chronic pain conditions.
Chiuve and colleagues also noted higher rates of UF in Black women, whom they said have higher rates of UF at younger ages, experience worse symptoms, and are more likely to have hysterectomies.
Researchers added that these hysterectomies were also more likely to be abdominal than laparoscopic.
They said that while Black women experience these greater health challenges related to UF, “rates of diagnosed depression and anxiety were not elevated in Black women.”1
According to Chiuve and colleagues, this could be due to the stigma of mental health issues for Black women, who may not report symptoms even though they have higher loads of stressors than White women due to racial disparities, researchers reported.
“Additional research is needed to understand whether these observed differences are due to differences in disease burden, clinical or cultural presentation of symptoms and/or access to healthcare,” they said.1
“Obstetricians and gynecologists can play an important role in early detection, prevention and treatment of mood disorders by screening for symptoms at routine examinations,” researchers concluded.1 They recommended a multidisciplinary approach to better manage depression, anxiety, and self-violence in women with UF.
Reference
Pap Talk S4E4: RFA and uterine fibroids with Dr. Jessica Shepherd
March 30th 2022In this episode of Pap Talk, Jessica Shepherd, MD, MBA, FACOG, deep dives into the benefits of utilizing radio frequency ablation (RFA) for treatment of uterine fibroids, available RFA devices, and disparities in the condition.
Listen
Physician-patient collaboration for uterine fibroid treatment options
May 12th 2021Contemporary OB/GYN®’s senior editor Angie DeRosa sat down with Ayman Al-Hendy, MD, and Sateria Venable of The Fibroid Foundation, to discuss the role of patient-physician collaboration in uterine fibroid treatment and management options.
Listen
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More
Maternal history linked to uterine fibroid risk in Black women
April 11th 2024Delve into the findings of a recent study revealing the heightened risk of developing uterine fibroids among Black women with a maternal history of the condition, shedding light on crucial implications for patient care and advocacy.
Read More